The S&P 500 fell 1.1% on Wednesday, March 26, 2025, as tech stocks faltered and the White House prepared to announce tariffs ...

It provides an AI copilot that gathers and analyzes patient data from the EHR and other disparate sources to facilit ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

Navina, a market leader in AI-powered clinical intelligence, today announced the successful completion of a $55 million Series C funding round, bringing the total funding to $100 million. The round is ...

Clinician AI assistant company Navina has raised a $55 million series C funding round, the company announced Tuesday.  | ...

The healthcare startup raised fresh Series C funding for its AI that helps clinics aggregate patient data to deliver better ...

Navina, a clinical intelligence company, closed a $55 million Series C funding round. The round was led by a division of ...

US stocks surged with strong gains in tech, banking, and airline sectors. Investors welcomed reports of scaled-back tariffs, fueling a bullish market mood.

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.

Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) have been assigned an average rating of “Hold” from the twenty-four ...

Danaher (NYSE:DHR) traded higher in the premarket on Friday after Goldman Sachs upgraded the life sciences company to Buy ...

Goldman Sachs analyst Chris Shibutani maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $136.00.